奥美拉唑联合铝碳酸镁治疗胃溃疡合并胃出血患者的临床效果与安全性分析(1)
【摘 要】目的:研究联合应用奥美拉唑、铝碳酸镁治疗胃溃疡合并胃出血患者的临床效果。方法:选择我院2017年10月-2018年10月中的80例胃溃疡合并胃出血患者进行研究,按照患者接受治疗的不同方式进行分组,观察组40例、对照组40例,分别接受奥美拉唑治疗、奥美拉唑联合铝碳酸镁治疗,比较两组效果。结果:观察组治疗总有效率为87.50%,高于对照组总有效率67.50%,P<0.05;观察组腹痛消失、腹胀消失、嗳气消失、呕血及便血消失均短于对照组,P<0.05;观察组治疗后不良反应发生率为12.50%,与对照组发生率10%没有统计学差异,P>0.05,观察组复发率为5%,低于对照组复发率20%,P<0.05。结论:奥美拉唑联合铝碳酸镁治疗胃溃疡合并胃出血能够更明显改善患者临床症状,获得更好的临床疗效,且治疗安全性较高,可在临床推广。【关键词】胃溃疡;胃出血;奥美拉唑;铝碳酸镁;治疗;效果;安全性
Abstract Objective: To study the clinical effects of combined application of omeprazole and magnesium aluminum carbonate in the treatment of patients with gastric ulcer and gastric hemorrhage. Methods: Eighty patients with gastric ulcer and gastric hemorrhage from October 2017 to October 1818 in our hospital were selected. The patients were divided according to the different ways of treatment. 40 patients in the observation group and 40 patients in the control group received Merprazole treatment ......
您现在查看是摘要页,全文长 3436 字符。